Karlin Dan

Karlin Dan is listed in filings as Chief Medical Officer at Definium Therapeutics, Inc.. This profile follows SEC Form 4 activity through Dec 27, 2024, including sale activity. Recent filings connect the profile to Definium Therapeutics, Inc. (DFTX). The current snapshot covers public activity from Jun 25, 2024 to Dec 27, 2024. Reported amounts are shown as $50.0K to $49.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.